Currently available agents include interferon-alfa, lamivudine, and adefovir dipivoxil. A 12-month or longer course of interferon-alfa treatment or re-treatment achieves sustained biochemical ...
[44] The on-drug or on-treatment efficacy of lamivudine or adefovir dipivoxil does not differ between treatment-naive and previously interferon-alfa-treated patients with HBeAg-negative CHB ...
Guidance on the use of capecitabine and tegafur with uracil for metastatic colorectal cancer TA61 27 May 2003 27 May 2003 Guidance on the use of drugs for early thrombolysis in the treatment of acute ...